SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+22.2%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$253M
AUM Growth
+$253M
(-30%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-58.05%
Top 10 Holdings %
Top 10 Hldgs %
99.76%
Holding
12
New
1
Increased
1
Reduced
2
Closed
1
Top Buys
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$8.44M |
| 2 |
Innoviva
INVA
|
$6.22M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$160M |
| 2 |
ADXS
Advaxis, Inc.
ADXS
|
$1.31M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$405K |
Sector Composition
| 1 | Healthcare | 66.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
1
DELISTED
Medicines Co
MDCO
| $85.7M | 33.86% | 1,752,000 | – | – |
|
2
Biogen
BIIB
$19.4B
| $84.8M | 33.49% | 310,000 | – | – |
|
|
3
Innoviva
INVA
$1.29B
| $47.4M | 18.72% | 3,425,000 +450,000 | +15% | +$6.22M |
|
|
NVLN
4
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $11M | 4.35% | 1,025,000 | – | – |
|
|
BIVV
5
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $8.44M | 3.34% | +155,000 | New | +$8.44M |
|
|
ITCI
6
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.85M | 2.31% | 360,000 | – | – |
|
|
SEEL
7
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $3.06M | 1.21% | 1,447,906 | – | – |
|
|
VVUS
8
DELISTED
Vivus Inc
VVUS
| $2.88M | 1.14% | 2,573,943 | – | – |
|
|
ADXS
9
DELISTED
Advaxis, Inc.
ADXS
| $2.77M | 1.1% | 339,180 -160,820 | -32% | -$1.31M |
|
10
AbbVie
ABBV
$372B
| $651K | 0.26% | 10,000 | – | – |
|
|
AVEO
11
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $598K | 0.24% | 1,013,616 -686,384 | -40% | -$405K |
|
|
ARIA
12
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| – | – | -12,850,000 | Closed | -$160M |
|